In the BioHarmony Drug Report Database

"Preview" Icon

Efinaconazole

Jublia (efinaconazole) is a small molecule pharmaceutical. Efinaconazole was first approved as Jublia on 2014-06-06. It is used to treat mycoses and onychomycosis in the USA. Jublia’s patents are valid until 2035-04-25 (FDA).

 

Trade Name

 

Jublia
 

Common Name

 

efinaconazole
 

ChEMBL ID

 

CHEMBL2103877
 

Indication

 

mycoses, onychomycosis
 

Drug Class

 

Systemic antifungals (miconazole type); Fc fusion protein

Image (chem structure or protein)

Efinaconazole structure rendering